|
|
Post by derekewhitlock on Sept 2, 2021 7:41:03 GMT -5
Maybe a dumb question but here goes, can insiders of a company sell stock if they know of a material event, ie. the buyout of another company and/or product line, that is scheduled to take place? I am just curious about the recent selling by the recent selling by UTHR insiders. Thank you in advance for any insight,
|
|
|
|
Post by dh4mizzou on Sept 2, 2021 7:44:56 GMT -5
If they are caught there can be hefty monetary penalties AND prison time if I understand correctly.
|
|
|
|
Post by oldfishtowner on Sept 2, 2021 8:01:18 GMT -5
Peppy, thanks. But that's pretty standard right? All companies have authorized shares that are "in the bank" so to speak. I was getting the impression that you were implying that a major dilution was upcoming. Ackerman et al founded the shell company that was used to take NRXP public. Likely they hold the additional shares that have been issued but are not part of the float, since they are tightly held. In addition to the fact that the VIP is a generic drug, the overhang of these additional shares has been a concern of mine because at some point they will want to sell a portion of their shares.
My money is on MNKD.
|
|
|
|
Post by goyocafe on Sept 2, 2021 8:15:21 GMT -5
|
|
|
|
Post by uvula on Sept 2, 2021 8:26:40 GMT -5
Maybe a dumb question but here goes, can insiders of a company sell stock if they know of a material event, ie. the buyout of another company and/or product line, that is scheduled to take place? I am just curious about the recent selling by the recent selling by UTHR insiders. Thank you in advance for any insight, They can set up pre-planned sales ahead of time. Perfectly legal. |
|
|
|
Post by Clement on Sept 2, 2021 8:29:25 GMT -5
"Lung Biotechnology was established in 2006 ( originally called LungRx) as part of United Therapeutics' work to address the severe shortage of transplantable organs in the U.S. The company focuses on technologies that either delay the need for transplants or expand the supply of donor organs." www.lungbioengineering.com/patients/about-us/#our-story |
|
|
|
Post by goyocafe on Sept 2, 2021 8:32:10 GMT -5
"Lung Biotechnology was established in 2006 ( originally called LungRx) as part of United Therapeutics' work to address the severe shortage of transplantable organs in the U.S. The company focuses on technologies that either delay the need for transplants or expand the supply of donor organs." www.lungbioengineering.com/patients/about-us/#our-storySo what happened to Aviptadil in 2010? |
|
|
|
Post by peppy on Sept 2, 2021 8:34:07 GMT -5
Maybe a dumb question but here goes, can insiders of a company sell stock if they know of a material event, ie. the buyout of another company and/or product line, that is scheduled to take place? I am just curious about the recent selling by the recent selling by UTHR insiders. Thank you in advance for any insight, They can set up pre-planned sales ahead of time. Perfectly legal. Getting back to the question, Why would the insiders sell? The hold the keys to the kingdom. Look at the secondary end point the oxygenation levels. This could be seen in the Neo natal intensive care units as well after End tracheal surfactant was delivered per ET tube after birth for premature infants. The babies could wean off the ventilators. Surfactant has been around for years and the FDA knows that.  |
|
|
|
Post by dh4mizzou on Sept 2, 2021 8:37:40 GMT -5
Maybe a dumb question but here goes, can insiders of a company sell stock if they know of a material event, ie. the buyout of another company and/or product line, that is scheduled to take place? I am just curious about the recent selling by the recent selling by UTHR insiders. Thank you in advance for any insight, They can set up pre-planned sales ahead of time. Perfectly legal. True but I took the question to mean that they were buying/selling a day or two before the material news was made public. |
|
|
|
Post by cjm18 on Sept 2, 2021 8:39:54 GMT -5
I’d buy wish or more Mnkd
|
|
|
|
Post by lazyb767 on Sept 2, 2021 9:10:23 GMT -5
Maybe a dumb question but here goes, can insiders of a company sell stock if they know of a material event, ie. the buyout of another company and/or product line, that is scheduled to take place? I am just curious about the recent selling by the recent selling by UTHR insiders. Thank you in advance for any insight, Mere bloviation, somewhere between riffing and ruminating...  The timing may be merely coincidental. I'm not recalling the dollar amounts and too lazy at this time to check the corporate notes, but often insiders are selling to cover the tax liabilities of exercising stock options, that are offered periodically as compensation. That's just my opinion, I could be wrong... |
|
|
|
Post by hellodolly on Sept 2, 2021 9:17:13 GMT -5
I hold NRXP and MNKD. It won't hurt to add UTHR, soon. I just sold half my position in MYOV yesterday and was looking for something to buy. I'll need to look at the charts.
EDIT: Added 25 shares of UTHR this a.m. on the red candle.
|
|
|
|
Post by peppy on Sept 2, 2021 9:24:50 GMT -5
|
|
|
|
Post by casualinvestor on Sept 3, 2021 10:19:55 GMT -5
For the original question, MNKD is the most like to deliver a good gain. I already have enough MNKD stock though So I dipped my toes in NRXP after looking around. Some highlights: * The stock has been a $9-$12 stock for a long long time, until it ripped to $58 early this year * The company just raised ~$30M for 2.7M shares ($11) and 2.7M warrants ($12) * The company is very closely held by insiders. Of ~29M shares, insiders have ~19M * Institutions had 3M shares as of July 1st. Not a lot left for retail * Short % looks low, but cost to short is sky-high, with people reporting they are getting paid 35-50% to lend shares. This is partly because of insiders holding so many shares * They have a placebo-controlled trial mostly done: clinicaltrials.gov/ct2/show/NCT04311697 as well as a couple others for ZYESAMI * NIH interest in the treatment * EUA submitted 3 months ago * They have worldwide rights to the BriLife vaccine, although that's still waiting on a phase 2b/3 study to start: clinicaltrials.gov/ct2/show/NCT04990466 |
|
|
|
Post by winner on Sept 3, 2021 10:47:50 GMT -5
Decided to attempt to take a position. Just put a buy order in for 1535 shares at $15.47. I wish me ( and others) lots of luck.
|
|
